Clinical Trials

Why take part in a clinical trial?

Clinical trials are at the heart of finding a cure for type 1 diabetes, and are a crucial step to making new treatments, devices and therapies available to the public. These clinical trials are only made possible by volunteers willing to give up their time to take part.

Why Volunteer?

By volunteering for a clinical trial, you can help us to discover new ways of treating and ultimately curing T1D. Here are five more reasons to volunteer:
  • You could get access to new therapies before they are available on the market
  • You’ll learn more about your own T1D and how to manage it
  • You’ll help to advance research progress
  • You’ll contribute to making new therapies accessible to people with T1D
  • You could help find a cure for the millions of people worldwide living with T1D

How Does a Clinical Trial Work?

Read our blog post on all the ins and outs of how clinical trials work.

Find a Clinical Trial

Researchers across Aotearoa are running clinical trials for people at different ages and stages of type 1 diabetes. Check out the latest clinical trials to find one near you.

The closed loop therapy study will trial the world’s most advanced commercial automated insulin delivery system (MiniMed™ 780G) in youth with broad ethnic backgrounds. The study will identify if AHCL is an appropriate and safe therapy for youth struggling with diabetes. While better control of glucose levels is a key outcome for this trial, other features such as burden reduction, improved quality of life and treatment satisfaction will also be explored.

This world-first longitudinal study will be an important step towards integrating AHCL technology into regular diabetes care for youth, with the expectation that it will reduce daily diabetes management burden and improve short-term and long-term health outcomes in this high risk group.

For more information, contact Associate Professor Ben Wheeler.

Key Requirements
  • Age: 13 – 25 years
  • Diagnosed with Type1 Diabetes
  • History of HbA1c levels ≥ 69 mmol/mol
  • Using traditional injection therapy

New technology, like the intermittently scanned continuous glucose monitoring (isCGM; FreeSyle® Libre 2) could improve glucose monitoring and diabetes control for children, as it discreetly provides accurate and up-to-date glucose information.

The Flash-2 study aims to investigate the isCGM device using a randomised controlled trial in 100 young NZ children (aged 4-13 years). Given children’s propensity for new technology, the ease of being able to scan (even through clothing), and the reduction in finger pricking, isCGM may provide a great opportunity to engage children in their diabetes care and help them and their families to improve self-management behaviours.

This study continues the research group’s broad aim of helping to provide healthier, more equitable and cost-effective diabetes care to children and their families.

Key Requirements

  • Age: 4 – 13 years
  • Diagnosed with Type1 Diabetes
  • Parental permission

To find out if your child is eligible for this study please contact Associate Professor Ben Wheeler.


Researchers: is your T1D clinical trial not displayed here?

We collect personal information from you, including information about your name, contact information and location. We collect your personal information in order to get in contact with you. You have the right to ask for a copy of any personal information we hold about you, and to ask for it to be corrected if you think it is wrong. If you’d like to ask for a copy of your information, or to have it corrected, please contact us here.